Inventor · disambiguated record
Sven Mensing
Also filed as: MENSING SVEN
12 granted patents·17 pending applications·167 citations·filing 2012–2024
92Inventor score
Top patents by PatentIndex Score
29 records- 0195US8993578B2Methods for treating HCVABBVIE INC·Filed 2013·Granted Mar 31, 2015·15 cites·2 claims
- 0295US8969357B2Methods for treating HCVABBVIE INC·Filed 2013·Granted Mar 3, 2015·14 cites·2 claims
- 0395US8685984B2Methods for treating HCVABBVIE INC·Filed 2013·Granted Apr 1, 2014·19 cites·20 claims
- 0495US8680106B2Methods for treating HCVABBVIE INC·Filed 2013·Granted Mar 25, 2014·16 cites·20 claims
- 0595US8492386B2Methods for treating HCVBERNSTEIN BARRY M·Filed 2012·Granted Jul 23, 2013·28 cites·16 claims
- 0695US8466159B2Methods for treating HCVBERNSTEIN BARRY M·Filed 2012·Granted Jun 18, 2013·33 cites·16 claims
- 0792US8809265B2Methods for treating HCVABBVIE INC·Filed 2012·Granted Aug 19, 2014·21 cites·11 claims
- 0889US8853176B2Methods for treating HCVABBVIE INC·Filed 2012·Granted Oct 7, 2014·12 cites·3 claims
- 0986US10286029B2Method for treating HCVABBVIE INC·Filed 2015·Granted May 14, 2019·7 cites·34 claims
- 1077US11484534B2Methods for treating HCVABBVIE INC·Filed 2017·Granted Nov 1, 2022·1 cites·23 claims
- 1172US11285159B2Dosing regimens for use in treating myelofibrosis and MPN-related disorders with navitoclaxABBVIE INC·Filed 2020·Granted Mar 29, 2022·1 cites·42 claims
- 1271US2024232171A1Methods for Treating HCVABBVIE INC·Filed 2024·Application pending·0 cites
- 1368US2025057837A1Methods for Treating HCVABBVIE INC·Filed 2024·Application pending·0 cites
- 1465US2024115650A1Methods for Treating HCVABBVIE INC·Filed 2023·Application pending·0 cites
- 1560US2015164976A1Methods for Treating HCVABBVIE INC·Filed 2015·Application pending·0 cites
- 1660US2015196615A1Methods for Treating HCVABBVIE INC·Filed 2015·Application pending·0 cites
- 1759US9452194B2Methods for treating HCVABBVIE INC·Filed 2014·Granted Sep 27, 2016·0 cites·9 claims
- 1857US2014093516A1Human antibodies that bind the p40 subunit of human il-12/il-23 and uses thereforHRUSKA MATTHEW·Filed 2013·Application pending·0 cites
- 1955US2022288153A1Methods for Treating HCVABBVIE INC·Filed 2021·Application pending·0 cites
- 2054US2023019186A1Dosing regimens for use in treating myelofibrosis and mpn-related disorders with navitoclaxABBVIE INC·Filed 2022·Application pending·0 cites
- 2153US2018177779A1Methods for Treating HCVABBVIE INC·Filed 2016·Application pending·0 cites
- 2253US2023385268A1Methods for Treating HCVABBVIE INC·Filed 2023·Application pending·0 cites
- 2352US2015011481A1Methods for Treating HCVABBVIE INC·Filed 2014·Application pending·0 cites
- 2452US2014323395A1Methods for Treating HCVABBVIE INC·Filed 2014·Application pending·0 cites
- 2551US2019336565A1Methods for Treating HCVABBVIE INC·Filed 2019·Application pending·0 cites
- 2648US2021023012A1Solid Pharmaceutical Compositions for Treating HCVABBVIE INC·Filed 2020·Application pending·0 cites
- 2745US2018042982A1Methods for Treating HCVABBVIE INC·Filed 2017·Application pending·0 cites
- 2844US2012225080A1Human antibodies that bind the p40 subunit of human il-12/il-23 and uses thereforHRUSKA MATTHEW W·Filed 2012·Application pending·0 cites
- 2941US2018177778A1Methods for Treating HCVABBVIE INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sven Mensing files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →